AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. ACN
10. USO

Go back to AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance

AngioDynamics (ANGO) Tops Q1 EPS by 1c, Offers Guidance

October 4, 2023 7:05 AM EDT

AngioDynamics (NASDAQ: ANGO) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $78.7 million versus the consensus estimate of $77.69 million.

GUIDANCE:

AngioDynamics sees FY2024 EPS of ($0.28)-($0.34), versus the consensus of ($0.32). AngioDynamics sees... More